SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000053417-12-000119
Filing Date
2012-02-14
Accepted
2012-02-13 18:11:26
Documents
1

Document Format Files

Seq Description Document Type Size
1 VERTEX PHARMACEUTICALS INC 13G ANNUAL FILING vrtx1211.txt SC 13G 7138
  Complete submission text file 0000053417-12-000119.txt   8574
Mailing Address 466 LEXINGTON AVE NEW YORK NY 10017
Business Address 466 LEXINGTON AVE NEW YORK NY 10017 2124211000
JENNISON ASSOCIATES LLC (Filed by) CIK: 0000053417 (see all company filings)

IRS No.: 132631108 | State of Incorp.: NY | Fiscal Year End: 1231
Type: SC 13G

Mailing Address
Business Address 130 WAVERLY STREET CAMBRIDGE MA 02139-4242 6165776000
VERTEX PHARMACEUTICALS INC / MA (Subject) CIK: 0000875320 (see all company filings)

IRS No.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-42126 | Film No.: 12600935
SIC: 2834 Pharmaceutical Preparations